Catalyst Wire Dossier Catalyst Wire Dossier

Vepoloxamer

· Mast Therapeutics, Inc.
Drug timelines are a Plus or Pro feature.

2 regulatory and trial events tracked for Vepoloxamer, covering 2016-10-28 to 2016-12-22. Get the full timeline:

Most recent: Clinical Trial Update: Study of the Effect of Renal Impairment on the Pharmacokinetics of Vepoloxamer [Phase 1]

See pricing